Cookies?
Library Header Image
LSE Research Online LSE Library Services

"Kanavos, Panos"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Number of items: 104.

Article

Grimaccia, Federico and Kanavos, Panos (2014) Cost, outcomes, treatment pathways and challenges for diabetes care in Italy. Globalization and Health, 10 (58). ISSN 1744-8603

Vandoros, Sotiris and Kanavos, Panos (2014) Parallel trade and pharmaceutical prices: a game-theoretic approach and empirical evidence from the European Union. The World Economy, 37 (6). pp. 856-880. ISSN 0378-5920

Ferrario, Alessandra, Sautenkova, Nina, Bezverhni, Zinaida, Seicas, Rita, Habicht, Jarno, Kanavos, Panos and Safta, Vladimir (2014) An in-depth analysis of pharmaceutical regulation in the Republic of Moldova. Journal of Pharmaceutical Policy and Practice, 7 (1). p. 4. ISSN 2052-3211

Tordrup, David, Mossman, Jean and Kanavos, Panos (2014) Responsiveness of the EQ-5D to clinical change: is the patient experience adequately represented? International Journal of Technology Assessment in Health Care, 30 (01). pp. 10-19. ISSN 0266-4623

Bertoldi, Andréa D., Kanavos, Panos, França, Giovanny V. A., Carraro, André, Tejada, Cesar Augusto, Hallal, Pedro C., Ferrario, Alessandra and Schmidt, Maria (2013) Epidemiology, management, complications and costs associated with type 2 diabetes in Brazil: a comprehensive literature review. Globalization and Health, 9 (1). p. 62. ISSN 1744-8603

Tordrup, David, Angelis, Aris and Kanavos, Panos (2013) Preferences on policy options for ensuring the financial sustainability of health care services in the future: results of a stakeholder survey (Review). Applied Health Economics and Health Policy, 11 (6). pp. 639-652. ISSN 1175-5652

Jackson, Timothy L., Nicod, Elena, Angelis, Aris, Grimaccia, Federico, Prevost, Andrew T., Simpson, Andrew R.H. and Kanavos, Panos (2013) Pars plana vitrectomy for vitreomacular traction syndrome: a systematic review and metaanalysis of safety and efficacy. Retina, 33 (10). pp. 2012-2017. ISSN 0275-004X

Tordrup, David, Angelis, Aris and Kanavos, Panos (2013) Preferences on policy options for ensuring the financial sustainability of health care services in the future: results of a stakeholder survey. Applied Health Economics and Health Policy . pp. 1-14. ISSN 1175-5652

Jackson, Timothy L., Nicod, Elena, Angelis, Aris, Grimaccia, Federico, Prevost, Toby, Simpson, Andrew and Kanavos, Panos (2013) Vitreous attachment in age-related macular degeneration, diabetic macular edema, and retinal vein occlusion. Retina, 33 (6). pp. 1099-1108. ISSN 1539-2864

Kanavos, Panos, Ferrario, Alessandra, Vandoros, Sotiris and Anderson, Gerard F. (2013) Higher US branded drug prices and spending compared to other countries may stem partly from quick uptake of new drugs. Health Affairs, 32 (4). pp. 753-761. ISSN 0278-2715

Tordrup, David, Ahmed, Waqas, Bukhari, Khalid Saeed and Kanavos, Panos (2013) Availability of medical supplies during the 2010 Pakistan floods. Lancet Global Health, 1 (1). e13-e14. ISSN 2214-109X

Jackson, Timothy, Nicod, Elena, Simpson, Andrew, Angelis, Aris, Grimaccia, Federico and Kanavos, Panos (2013) Symptomatic vitreomacular adhesion. Retina, 33 (8). pp. 1503-1511. ISSN 1539-2864

Vandoros, Sotiris and Kanavos, Panos (2013) The generics paradox revisited: empirical evidence from regulated markets. Applied Economics, 45 (22). pp. 3230-3239. ISSN 0003-6846

Nicod, Elena and Kanavos, Panos (2012) Commonalities and differences in HTA outcomes: a comparative analysis of five countries and implications for coverage decisions. Health Policy, 108 (2-3). pp. 167-177. ISSN 0168-8510

Kanavos, Panos and Nicod, Elena (2012) What is wrong with orphan drug policies?: suggestions for ways forward. Value in Health, 15 (8). pp. 1182-1184. ISSN 1098-3015

Linertová, Renata, Serrano-Aguilar, Pedro, Posada-de-la-Paz, Manuel, Hens-Pérez, Manuel, Kanavos, Panos, Taruscio, Domenica, Schieppati, Arrigo, Stefanov, Rumen, Péntek, Márta, Delgado, Claudia, Graf von der Schulenburg, Johann-Matthias, Persson, Ulf, Chevreul, Karine, Fattore, Giovanni, Worbes-Cerezo, Melany, Sefton, Mark and López-Bastida, Julio (2012) Delphi approach to select rare diseases for a European representative survey: the BURQOL-RD study. Health Policy, 108 (1). pp. 19-26. ISSN 0168-8510

Prinja, Shankar, Aggarwal, Arun Kumar, Kumar, Rajesh and Kanavos, Panos (2012) User charges in health care: evidence of effect on service utilization & equity from north India. Indian Journal of Medical Research, Supplement , 136 . pp. 868-876. ISSN 0367-9012

Prinja, Shankar, Kanavos, Panos and Kumar, Rajesh (2012) Health care inequities in north India: role of public sector in universalizing health care. Indian Journal of Medical Research, 136 . pp. 421-431. ISSN 0971-5916

Helfer, Ana Paula, Camargo, Aline Lins, Tavares, Noemia Urruth Leão, Kanavos, Panos and Bertoldi, Andréa Dâmaso (2012) Capacidade aquisitiva e disponibilidade de medicamentos para doenças crônicas no setor público. Revista Panamericana de Salud Pública / Pan American Journal of Public Health, 31 (3). pp. 225-232. ISSN 1020-4989

Von der Schulenburg, Fritz, Vandoros, Sotiris and Kanavos, Panos (2011) The effects of drug market regulation on pharmaceutical prices in Europe: overview and evidence from the market of ACE inhibitors. Health Economics Review, 1 (1). pp. 1-8. ISSN 2191-1991

Kanavos, Panos G. and Vandoros, Sotiris (2011) Determinants of branded prescription medicine prices in OECD countries. Health Economics, Policy and Law, 6 (3). pp. 1-31. ISSN 1744-1331

Sorenson, Corinna and Kanavos, Panos (2011) Medical technology procurement in Europe: a cross-country comparison of current practice and policy. Health Policy, 100 (1). pp. 43-50. ISSN 0168-8510

Kanavos, Panos and Vandoros, Sotiris (2011) Drugs US: are prices too high?: measuring international pharmaceutical price differences. Significance, 8 (1). pp. 15-18. ISSN 1740-9705

Kanavos, Panos and Gemmill-Toyama, Marin (2010) Prescription drug coverage among elderly and disabled Americans: can Medicare—Part D reduce inequities in access? International Journal of Health Care Finance and Economics, 10 (3). pp. 203-218. ISSN 1389-6563

Kanavos, Panos and Vandoros, Sotiris (2010) Competition in prescription drug markets: is parallel trade the answer? Managerial and Decision Economics, 31 (5). pp. 325-338. ISSN 0143-6570

Lluch, Maria and Kanavos, Panos (2010) Impact of regulation of community pharmacies on efficiency, access and equity. Evidence from the UK and Spain. Health Policy, 95 (2-3). pp. 245-254. ISSN 0168-8510

Kanavos, Panos, Sullivan, R., Lewison, G., Schurer, W., Eckhouse, S. and Vlachopioti, Z. (2010) The role of funding and policies on innovation in cancer drug development. Ecancermedicalscience, 4 . ISSN 1754-6605

Geitona, Mary and Kanavos, Panos (2010) Colocteral cancer management and prevention policies in Greece. The European Journal of Health Economics, 10 (Supp.1). pp. 27-33. ISSN 1618-7598

Schurer, Willemien and Kanavos, Panos (2010) Colorectal cancer management in the United Kingdom: current practice and challenges. The European Journal of Health Economics, 10 (Supp.1). pp. 85-90. ISSN 1618-7598

Kanavos, Panos and Schurer, Willemien (2010) The burden of colorectal cancer: prevention, treatment and quality of services. The European Journal of Health Economics, 10 (Supp.1). pp. 1-3. ISSN 1618-7598

Kanavos, Panos and Schurer, Willemien (2010) The dynamics of colorectal cancer management in 17 countries. The European Journal of Health Economics, 10 (Supp.1). pp. 115-129. ISSN 1618-7598

Kanavos, Panos, Nicod, Elena, van den Aardweg, Stacey and Pomedli, Stephen (2010) The impact of health technology assessments: an international comparison. Euro Observer, 12 (4). pp. 1-7. ISSN 1020-7481

Sorenson, Corinna, Kanavos, Panos and Karamalis, M. (2009) HTA in Central and Eastern Europe: current status, challenges and opportunities. Journal of Medical Device Regulation, 6 (1). pp. 34-45. ISSN 1759-149X

Kanavos, Panos, Vandoros, Sotiris and Garcia-Gonzalez, Pat (2009) Benefits of global partnerships to facilitate access to medicines in developing countries: a multi-country analysis of patients and patient outcomes in GIPAP. Globalization and Health, 5 (19). pp. 1-13. ISSN 1744-8603

Sorenson, Corinna, Drummond, Michael, Kanavos, Panos and McGuire, Alistair (2008) Does the work of the National Institute for Health and Clinical Excellence (NICE) have any relevance for the United States? Ispor Connections, 14 (4). pp. 7-9. ISSN 1538-5108

Kanavos, Panos, Costa-i-Font, Joan and Seeley, Elizabeth (2008) Competition in off-patent drug markets: issues, regulation and evidence. Economic Policy, 23 (55). pp. 499-544. ISSN 0266-4658

McGuire, Alistair, Raikou, Maria and Kanavos, Panos (2008) Pricing pharmaceuticals: value based pricing in what sense? Eurohealth, 14 (2). pp. 3-6. ISSN 1356-1030

Kanavos, Panos (2007) Do generics offer significant savings to the UK National Health Service? Current Medical Research and Opinion, vol. 23(1). Current Medical Research and Opinion, 23 (1). pp. 105-116. ISSN 0300-7995

Costa-i-Font, Joan, Kanavos, Panos and Rovira-Forns, Joan (2007) Determinants of out-of-pocket pharmaceutical expenditure and access to drugs in Catalonia. Applied Economics, 39 (5). pp. 541-551. ISSN 0003-6846

Costa-i-Font, Joan and Kanavos, Panos (2007) Importaciones paralelas de medicamentos: El caso de la Simvastaina en Alemania, Holanda y el Reino Unido. Gaceta Sanitaria, 21 (1). pp. 53-59. ISSN 0213-9111

Kanavos, Panos, Costa-i-Font, Joan and McGuire, Alistair (2007) Product differentiation, competition and regulation of new drugs: the case of statins in four European countries. Managerial and Decision Economics, 28 (4-5). pp. 455-465. ISSN 1099-1468

Gemmill, Marin, Costa-i-Font, Joan and Kanavos, Panos (2006) Insurance coverage and the heterogeneity of health and drug spending in the United States. Geneva Papers on Risk and Insurance, 31 (4). pp. 669-691. ISSN 1018-5895

Morgan, S, McMahon, M, Mitton, C, Rougehead, E, Kirk, R, Kanavos, Panos and Menom, D (2006) Centralized drug review processes in Australia, Canada, New Zealand, and the United Kingdom. Health Affairs, 25 (2). pp. 337-347. ISSN 0278-2715

Kanavos, Panos and Saka, R (2006) Economic evaluation for orphan drugs: is it possible? Eurohealth . ISSN 1356-1030

Tatar, Mehtap and Kanavos, Panos (2006) Health care reform in Turkey: a dynamic path in the wake of political consensus. Eurohealth, 12 (1). pp. 20-22. ISSN 1356-1030

Kanavos, Panos, Yfantopoulos, J., Politis, C. and Vandoros, C. (2006) The economics of blood: gift of life or a commodity? International Journal of Technology Assessment in Health Care, 22 (3). pp. 338-343. ISSN 0266-4623

Kanavos, Panos (2006) The rising burden of cancer in the developing world. Annals of Oncology, 17 (Supple). ISSN 0923-7534

Kanavos, Panos and Costa-i-Font, Joan (2005) Pharmaceutical parallel trade in Europe: stakeholders and competition effects. Economic Policy, 20 (44). pp. 751-798. ISSN 0266-4658

Park, Sylvia, Ross-Degnan, Dennis, Adams, Alyce S, Sabin, James, Kanavos, Panagiotis and Soumerai, Stephen B (2005) Effect of switching antipsychotics on antiparkinsonian medication use in schizophrenia: a population-based study. British Journal of Psychiatry, 187 (2). pp. 137-142. ISSN 0007-1250

Knapp, Martin, Kanavos, Panos, King, Derek and Yesudian, Hannah Monica (2005) Economic issues in access to medications: Schizophrenia treatment in England. International Journal of Law and Psychiatry, 28 (5). pp. 514-531. ISSN 0160-2527

Costa-i-Font, Joan and Kanavos, Panos (2005) Efectos del comercio paralelo de medicamentos en la Unión Europea y evidencia de Alemania. Boletin de Estudios Economicos, 60 (185). pp. 251-263. ISSN 0006-6249

Kanavos, Panos and Saka, Ömer R (2005) How should functionally equivalent drugs be reimbursed? A retrospective analysis of reimbursement for Epoetin-[alpha] and Darbepoetin-[alpha] in 2001-2003 and the cost implications for CMS. Disease Management and Health Outcomes, 13 (6). pp. 359-370. ISSN 1173-8790

Kanavos, Panos and Saka, O (2005) How should functionally equivalent drugs be reimbursed?: A retrospective analysis of reimbursement for epoetin alfa and Darbepoetin alfa in 2001–3 and the cost implications for CMS. Disease Management and Health Outcomes, 13 (6). pp. 359-370. ISSN 1173-8790

Kanavos, Panos and Gemmill, M (2004) Senior citizens and the burden of prescription drug outlays: what lessons for the Medicare prescription drug benefit? Applied Health Economics and Health Policy, 3 (4). pp. 217-227. ISSN 1175-5652

Kanavos, Panos (2003) Reference pricing for drugs: is it compatible with US healthcare? Health Affairs, 22 (3). pp. 16-30. ISSN 0278-2715

King, Derek R. and Kanavos, Panos (2002) Encouraging the use of generic medicines: implications for transition economies. Croatian Medical Journal, 43 (4). pp. 462-469. ISSN 0353-9504

Kanavos, Panos (2002) EU pharmaceutical policy: the challenges and opportunities of enlargement. Eurohealth, 8 (4). pp. 24-26. ISSN 1356-1030

Kanavos, Panos, Trueman, P and Bosilevac, A (2000) Can economic evaluation guidelines improve efficiency in resource allocation? International Journal of Technology Assessment in Health Care, 16 (4). pp. 1179-1192. ISSN 0266-4623

Kanavos, Panos and McKee, Martin (2000) Cross-border issues in the provision of health services: are we moving towards a European health policy? Journal of Health Services Research and Policy, 5 (4). pp. 231-236. ISSN 1355-8196

Maynard, Alan and Kanavos, Panos (2000) Health economics: an evolving paradigm. Health Economics, 9 (3). pp. 183-190. ISSN 1057-9230

Kanavos, Panos (2000) Towards evidence-based decisions in health care: a prospective assessment of training needs in health economics and management in the European Union. Hepac (Health Economics in Prevention and Care), 1 (1). pp. 78-90. ISSN 1439-3972

Trueman, P., Kanavos, Panos and Wallace, M. (2000) The increasing use of economic evaluation of pharmaceuticals, part 1: guidelines for economic evaluation and their role in health policy. Clinical Research Focus, 11 (1). pp. 23-29. ISSN 0968-0594

Trueman, P., Kanavos, Panos and Wallace, M. (2000) The increasing use of economic evaluation of pharmaceuticals, part 2: 'the fourth hurdle': what does it mean for drug development? Clinical Research Focus, 11 (2). pp. 24-29. ISSN 0968-0594

Kanavos, Panos (2000) The single market for pharmaceuticals in the European Union in light of European Court of Justice rulings. Pharmacoeconomics, 18 (6). pp. 523-532. ISSN 1170-7690

Kanavos, Panos (1999) Financing pharmaceuticals in transition. Croatian Medical Journal, 40 (June). pp. 244-259. ISSN 0353-9504

Kanavos, Panos and Mossialos, Elias (1999) Outstanding regulatory issues in the European Union pharmaceutical market. Pharmacoeconomics, 15 (6). pp. 519-533. ISSN 1170-7690

Book Section

Kanavos, Panos and Wouters, Olivier J. (2014) Pharmaceutical parallel trade: legal, policy, and economic issues. In: Culyer, Anthony J., (ed.) Encyclopedia of health economics. Elsevier, San Diego, USA, pp. 20-28. ISBN 9780123756787

Kanavos, Panos, Soumerai, Stephen B and Ross-Degnan, Dennis (2004) Measuring, monitoring and evaluating policy outcomes in the pharmaceutical sector. In: Mossialos, Elias, Mrazek, Monique F. and Walley, Tom, (eds.) Regulating Pharmaceuticals in Europe: Striving for Efficiency, Equity and Quality. Open University Press on behalf of the European Observatory on Health Systems and Policies, Maidenhead, UK, pp. 97-113. ISBN 9780335214655

Kanavos, Panagiotis, Tatar, D and Taylor, D (2004) Regulating pharmaceutical distribution and retail pharmacy in Europe. In: Mossialos, Elias, Mrazek, M and Walley, T, (eds.) Regulating Pharmaceuticals in Europe : Striving for Efficiency, Equity and Quality. Open University Press, Maidenhead, UK, pp. 196-212. ISBN 0335214657

Kanavos, Panos (2003) Implications of financing systems. In: Zollner, H, Stoddart, G and Selby Smith, C, (eds.) Learning to Live With Health Economics. World Health Organization for Europe, pp. 69-86.

Kanavos, Panos and Mossialos, Elias (2003) Managing healthcare reform: evaluation of available options. In: Stoddart, G, Zollner, H and Selby-Smith, C, (eds.) Learning to Live With Healthcare Reform. World Health Organization Regional Office for Europe, Copenhagan, Denmark.

Kanavos, Panos and Mossialos, Elias (2002) Evaluation of health care reform options. In: Zollner, H, Stoddart, G and Selby Smith, C, (eds.) Learning to Live With Health Economics. World Health Economics for Europe, pp. 37-48.

Monograph

Ferrario, Alessandra and Kanavos, Panos (2013) Managed entry agreements for pharmaceuticals: the European experience. EMiNet, Brussels, Belgium.

Kanavos, Panos and Angelis, Aris (2013) Multiple criteria decision analysis for value based assessment of new medical technologies: a conceptual framework. LSE Health working papers, 33. LSE Health, London, UK.

Kanavos, Panos, van den Aardweg, Stacey and Schurer, Willemien (2012) Diabetes expenditure, burden of disease and management in 5 EU countries. The London School of Economics and Political Science, London, UK.

Sautenkova, Nina, Ferrario, Alessandra, Bolokhovets, Ganna and Kanavos, Panos (2012) Availability and affordability of medicines and assessment of quality systems for prescription of medicines in the Republic of Moldova: final report. Health policy paper series, no. 6. World Health Organization, Regional Office for Europe, Copenhagen, Denmark.

Kanavos, Panos, Schurer, Willemien and Vogler, Sabine (2011) The pharmaceutical distribution chain in the European Union: structure and impact on pharmaceutical prices. European Commission, Brussels, Belgium.

Kanavos, Panos, Vandoros, Sotiris, Irwin, Rachel, Nicod, Elena and Casson, Margaret (2011) Differences in costs of and access to pharmaceutical products in the EU. IP/A/ENVI/ST/2010-12 . European Parliament, Brussels.

Kanavos, Panos, Nicod, Elena, Espin, Jaime and van den Aardweg, Stacey (2010) Short- and long-term effects of value-based pricing vs. external price referencing. EMiNet.

Kanavos, Panos, Vandoros, Sotiris, Irwin, Rachel, Nicod, Elena and Casson, Margaret (2010) The European pharmaceutical market and policies - outlook for the future. European Parliament, Brussels, Belgium.

Kanavos, Panos, Seeley, Elizabeth and Vandoros, Sotiris (2009) Tender systems for outpatient pharmaceuticals in the European Union: evidence from the Netherlands, Germany and Belgium. Enterprise and Industry, European Commission, Brussels, Belgium.

Kanavos, Panos, Vandoros, Sotiris, Habicht, Jarno and de Joncheere, Kees (2009) Review of the Estonian pharmaceutical sector: towards the development of a national medicines policy. Regional Office for Europe, World Health Organization, Copenhagen, Denmark.

Sorenson, Corinna and Kanavos, Panos (2009) Topic 1: financing medical devices in France and the UK. European Health Technology Institute on Socio-Economic Research.

Kanavos, Panos, Schurer, Willemien, Owusu-Apenten, Candida and Sullivan, Richard (2008) Colorectal cancer in Europe and Australia: challenges and opportunities for the future. 9780853283027. LSE Health, London School of Economics and Political Science, London, UK. ISBN 9780853283027

Sorenson, Corinna, Drummond, Michael, Kanavos, Panos and McGuire, Alistair (2008) National Institute for Health and Clinical Excellence (NICE). How does it work and what are the implications for the U.S? National Pharmaceutical Council, Virginia, USA.

Kanavos, Panos and Vandoros, Sotiris (2008) Validation of the Russian federal prescribing database and evaluation of policy outcomes. Russian Federal Bureau of Obligatory Medical Insurance.

Costa-i-Font, Joan and Kanavos, Panos (2007) Medicines in parallel trade in the European Union: a gravity specification. LSE Health working papers, 6/2007. London School of Economics and Political Science, London, UK.

Kanavos, Panos, Ustel, I., Tatar, M. and Costa-i-Font, Joan (2006) Health and drug sector reform in Turkey: caveats and opportunities. Health and Social Care, London School of Economics and Political Science, London, UK.

Hockley, Tony, Kanavos, Panos and Rudisill, Caroline (2006) The IFPMA Health Partnerships Survey: a critical appraisal. London School of Economics and Political Science, London, UK.

Kanavos, Panos, Gross, David and Taylor, David (2005) Parallel trading in medicines: Europe’s experience and its implications for commercial drug importation in the United States. 2005-07. American Association for Retired Persons, Washington, DC., USA.

Kanavos, Panos, Costa-i-Font, Joan, Merkur, S. and Gemmill, M. (2004) The economic impact of pharmaceutical parallel trade in European union member states: a stakeholder analysis. Special Research Paper, London School of Economics and Political Science, London, UK. ISBN 0753017261

Kanavos, Panos and Holmes, P. R. (2004) Financial flows to global health partnerships. Department for International Development, London, UK.

Kanavos, Panos, Lim, J Y and Pascual, C S (2002) On improving accessibility of drugs for the poor. Philippines health policy note, The World Bank.

Kanavos, Panos, Lim, J Y and Pascual, C S (2002) On improving the poor's access to affordable drugs. The World Bank.

Kanavos, Panos (2001) Overview of pharmaceutical pricing and reimbursement regulation. LSE Health, London, U.K..

Conference or Workshop Item

Kanavos, Panos and Wouters, Olivier J. (2014) Concurrence dans la distribution de produits pharmaceutiques. In: OECD Forum Mondial sur la Concurrence, 27-28 Feb 2014, Paris, France.

Kanavos, Panos and Wouters, Olivier J. (2014) Competition issues in the distribution of pharmaceuticals. In: OECD Global Forum on Competition, 27-28 Feb 2014, Paris, France.

Sorenson, Corinna, Drummond, Michael and Kanavos, Panos (2007) Ensuring value for money in health care: The role of HTA in the European Union. In: Financing sustainable healthcare in Europe: New approaches for new outcomes, 7-8 February 2007, Helsinki, Finland.

Kanavos, Panos (2002) Pharmaceutical regulation in Europe. In: Institute for Research on Public Policy Conference – Toward a National Strategy on Drug Insurance: Challenges and Priorities, September 23 2002, Toronto, Ontario.

Book

Sorenson, Corinna, Drummond, Michael and Kanavos, Panos (2008) Ensuring value for money in health care: the role of health technology assessment in the European Union. Observatory studies series , 11 . World Health Organization Regional Office for Europe, Copenhagen, Denmark. ISBN 9789289071833

Kanavos, Panos, Holmes, P, Loudon, David and Benedict, Irvine (2005) Pharmaceutical parallel trade in the UK. CIVITAS, London, UK. ISBN 9781903386392

Kanavos, Panos and Gemmill, Marin (2005) Pharmaceutical pricing and reimbursement in Europe. Scrip reports . Scrip, London.

Website

Ferrario, Alessandra and Kanavos, Panos (2013) The LSE Summit: risk sharing and managed entry agreements. Health and Social Care at LSE (20 Nov 2013) Blog Entry.

Ferrario, Alessandra and Kanavos, Panos (2013) Progress in addressing the growing diabetes epidemic is lagging behind due to poor control of the disease. Health and Social Care at LSE (19 Jun 2013) Blog Entry.

This list was generated on Wed Aug 27 18:33:07 2014 BST.